SCHEMBL32686189

SCHEMBL32686189

Cc1c(C(=O)N2CCC(F)(F)CC2)sc2cc(-c3cnc4nn(C)cc4c3)ccc12

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.41
LIPC P11150 1/20 0.35
WNT1 P04628 6/20 0.34
GSK3B P49841 6/20 0.34
DYRK1A Q13627 6/20 0.34
GRM4 Q14833 2/20 0.33
RET P07949 1/20 0.33
SYK P43405 1/20 0.33
PIK3C3 Q8NEB9 1/20 0.33
FASN P49327 1/20 0.32
CCNC P24863 1/20 0.32
CDK8 P49336 1/20 0.32
HPGD P15428 1/20 0.32
GABRA1 P14867 1/20 0.32
GRM2 Q14416 1/20 0.31
GAK O14976 1/20 0.31
GRIN2B Q13224 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32686052 0.88 CES2 (0.42) CES2GSK3BDYRK1ACCNCCDK8
SCHEMBL32686053 0.88 CES2 (0.42) CES2GSK3BDYRK1ACCNCCDK8
SCHEMBL32686158 0.83 CES2 (0.38) CES2GSK3BDYRK1ASYKHPGD
SCHEMBL32685912 0.82 CES2 (0.40) CES2LIPCRETCCNCCDK8
SCHEMBL32686060 0.82 CES2 (0.40) CES2LIPCRETCCNCCDK8
SCHEMBL32686180 0.82 CES2 (0.40) CES2LIPCRETCCNCCDK8
SCHEMBL32685949 0.80 CES2 (0.43) CES2RETCCNCCDK8HPGD
SCHEMBL32686140 0.80 CES2 (0.43) CES2RETCCNCCDK8HPGD
SCHEMBL32686066 0.80 CES2 (0.43) CES2RETCCNCCDK8HPGD
SCHEMBL31315329 0.78 DYRK1A (0.45) WNT1GSK3BDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709480-A1 5,6-FUSED BICYCLIC AMIDES AND COMPOSITIONS FOR USE AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS Amgen Inc. (US) 2026-03-18 EP claimed
EP-4709480-A1 5,6-FUSED BICYCLIC AMIDES AND COMPOSITIONS FOR USE AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS Amgen Inc. (US) 2026-03-18 EP disclosed